Status:

COMPLETED

Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine

Lead Sponsor:

Janssen Pharmaceutica N.V., Belgium

Conditions:

HIV

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to investigate the pharmacokinetic interaction between etravirine and artemether/lumefantrine and darunavir/ritonavir and artemether/lumefantrine in healthy Human Immunode...

Detailed Description

This is a Phase I, partially randomized, open-label, single-center, two-way, two-period cross-over study to investigate the pharmacokinetic interaction between etravirine (ETR) or darunavir/ritonavir ...

Eligibility Criteria

Inclusion

  • if of childbearing potential or if male, use a highly effective method of birth control.
  • Able to comply with protocol requirements.
  • A BMI (weight in kg divided by the square of height in meters) of 18.5 to 30.0 kg/m2, extremes included.
  • healthy on the basis of a medical evaluation
  • Non-smoking for at least 3 months prior to selection.

Exclusion

  • previously demonstrated clinically significant allergy, hypersensitivity or intolerance to any of the investigational medications or its excipients
  • Use of concomitant medication, including over-the-counter products and dietary supplements.
  • Having participated in more than 1 study (single or multiple dose) with ETR (TMC125), DRV (TMC114), dapivirine (TMC120) and/or rilpivirine (TMC278, formerly known as R278474), or having developed a rash, erythema or urticaria while participating in a study with the aforementioned compounds.
  • A positive pregnancy test or breast feeding at screening or on Day 1.
  • Any condition that, in the opinion of the investigator, would compromise the study or the well-being of the patient or prevent the patient from meeting or performing study requirements

Key Trial Info

Start Date :

March 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2011

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT01876966

Start Date

March 1 2011

End Date

July 1 2011

Last Update

June 13 2013

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine | DecenTrialz